American Journal of Cardiology
Volume 96, Issue 10 , Pages 1389-1392 , 15 November 2005

Impact of Diabetes Mellitus on Angiographic and Clinical Outcomes in the Drug-Eluting Stents Era

  • Tae-Hyun Yang, MD

      Affiliations

    • Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center
    • ,
  • Seong-Wook Park, MD

      Affiliations

    • Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center
    • ,
  • Myeong-Ki Hong, MD

      Affiliations

    • Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center
    • ,
  • Duk-Woo Park, MD

      Affiliations

    • Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center
    • ,
  • Kyoung-Min Park, MD

      Affiliations

    • Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center
    • ,
  • Young-Hak Kim, MD

      Affiliations

    • Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center
    • ,
  • Ki-Hoon Han, MD

      Affiliations

    • Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center
    • ,
  • Cheol Whan Lee, MD

      Affiliations

    • Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center
    • ,
  • Sang-Sig Cheong, MD

      Affiliations

    • GangNeung, Seoul, Korea.
    • ,
  • Jae-Joong Kim, MD

      Affiliations

    • Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center
    • ,
  • Seung-Jung Park, MD

      Affiliations

    • Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center
    • Corresponding Author InformationCorresponding author: Tel: 82-2-3010-3152; fax: 82-2-475-6898.

Received 23 February 2005 ,Revised 27 June 2005 ,Accepted 27 June 2005.

References 

  1. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, et al  Sustained suppression of neointimal proliferation by sirolimus-eluting stents (one-year angiographic and intravascular ultrasound follow-up) . Circulation . 2001;104:2007–2011
  2. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, et al  Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (Randomized Study With the Sirolimus-Eluting Velocity Balloon-Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions) trial . Circulation . 2002;106:798–803
  3. Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, et al  Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries (a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT)) . Circulation . 2003;107:517–520
  4. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery . N Engl J Med . 2003;349:1315–1323
  5. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease . N Engl J Med . 2004;350:221–231
  6. Moussa I, Leon MB, Baim DS, O’Neill WW, Popma JJ, Buchbinder M, et al  Impact of sirolimus-eluting stents on outcome in diabetic patients (a SIRIUS (Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients With De Novo Coronary Artery Lesions) substudy) . Circulation . 2004;109:2273–2278
  7. Abizaid A, Costa MA, Blanchard D, Albertal M, Eltchaninoff H, Guagliumi G, et al  Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial . Eur Heart J . 2004;25:107–112
  8. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis (a randomized controlled trial) . JAMA . 2005;293:165–171

 This study was supported in part by the Cardiovascular Research Foundation, Seoul, Korea, and by Grant 0412-CR02-0704-0001 from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Seoul, Korea.

PII: S0002-9149(05)01374-3

doi: 10.1016/j.amjcard.2005.07.043

American Journal of Cardiology
Volume 96, Issue 10 , Pages 1389-1392 , 15 November 2005

Article Tools

* Image Usage & Resolution